ArticleAnnals of surgical oncology2026
Enhancing Early Detection of Contralateral Breast Cancer in Breast Cancer Survivors Using AI-Assisted Mammography.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWomen with a history of breast cancer face an elevated risk of developing contralateral breast cancer (CBC). Although annual mammographic screening is recommended, its sensitivity is limited, particularly in younger women and those with dense breast tissue. This study assessed the potential of artificial intelligence (AI)-based computer-aided diagnosis (AI-CAD) to improve CBC detection in a cohort of breast cancer survivors and to enhance early CBC detection.
methodsThis study included 454 women who developed CBC and 454 matched controls without recurrence. Mammograms were analyzed using AI-CAD software assigning abnormality scores from 0 to 100, with scores over 10 indicating CBC. Standalone AI predictions were compared with radiologists' initial assessments, and its ability to detect early signs of CBC in prior mammograms was evaluated.
resultsThe median age of patients was 53 years; the majority (79.9%) had dense breast tissue. Standalone AI detected 271 CBC cases solely from mammography, achieving 6.2% higher sensitivity compared with radiologists (59.7% vs. 53.5%, p = 0.009). Notably, AI detected 66 CBC cases (14.5%) that radiologists had missed on mammographic assessment alone. With respect to earlier detection, 81 cases (29.9%) were identified on prior mammograms at a median of 13.3 (9.6-19.9) months before clinical diagnosis. Of these, 28 cases (10.3%) were detected more than 6 months before pathological confirmation, and 53 cases (19.6%) more than 1 year earlier.
conclusionsAI-CAD may enhance the detection of CBC in breast cancer survivors and facilitate earlier identification on surveillance mammography. Further studies are needed to assess its integration into surveillance mammography and clinical impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.